Ikarovec is Biotechnology in United Kingdom that focus on diabetic macular edema business. Founded in 2018. They cover business area such as developer, ophthalmic gene therapy company, common eye disease, technology, multiple disease target, pathway, hence treatment, neovascular (wet-form) age-relate macular degeneration, ocular hypertension, patient, sight, blindness.
2018
( 8 years old in 2026 )
Diabetic Macular Edema
-
Innovation Centre
Norwich Research Park, Colney Lane
Norwich
England, United Kingdom
Private
developerophthalmic gene therapy companycommon eye diseasetechnologymultiple disease targetpathwayhence treatmentneovascular (wet-form) age-relate macular degenerationocular hypertensionpatientsightblindness
* We use standard office opening hours in near Ikarovec's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ikarovec is Biotechnology business from United Kingdom that founded in 2018 (8 years old in 2026), Ikarovec business is focusing on Diabetic Macular Edema.
Ikarovec headquarter office and corporate office address is located in Innovation Centre Norwich Research Park, Colney Lane Norwich England, United Kingdom.
Ikarovec was founded in United Kingdom.
In 2026, Ikarovec is currently focus on diabetic macular edema sector.
Above is snippet of Google Trends for "diabetic macular edema" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ikarovec, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
